Context Therapeutics Inc.
CNTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $61,337 | $18,042 | $10,405 | $7,538 |
| - Cash | $94,430 | $14,450 | $35,497 | $49,635 |
| + Debt | $219 | $0 | $55 | $0 |
| Enterprise Value | -$32,874 | $3,592 | -$25,037 | -$42,097 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$29,913 | -$25,061 | -$14,872 | -$10,393 |
| % Margin | – | – | – | – |
| Net Income | -$26,725 | -$23,964 | -$14,836 | -$10,457 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.46 | -1.5 | -0.93 | -3.69 |
| % Growth | 69.3% | -61.3% | 74.8% | – |
| Operating Cash Flow | -$14,556 | -$21,048 | -$13,549 | -$8,799 |
| Capital Expenditures | -$14,757 | $0 | -$537 | -$250 |
| Free Cash Flow | -$29,314 | -$21,048 | -$14,086 | -$9,049 |